Dr. Medford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-643-0596Fax+1 617-643-6443
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 2017 - 2019
- Johns Hopkins University School of MedicineClass of 2015
Certifications & Licensure
- MA State Medical License 2016 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis.Diana Zhang, Shayesteh Jahanfar, Judy B Rabinowitz, Joshua Dower, Fei Song
Breast Cancer Research. 2025-03-12 - Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.Emily L Podany, Lorenzo Foffano, Lorenzo Gerratana, Arielle J Medford, Katherine Clifton
JAMA Network Open. 2025-02-03 - 1 citationsIntegrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endo...Lorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, Carolina Reduzzi, Tania Rossi
Cancer Letters. 2025-01-28
Press Mentions
- Racial Disparities in Genomic Profiles, Treatment Found in Patients with Metastatic Breast CancerFebruary 28th, 2025
- Identifying Opportunities to De-Escalate Adjuvant Therapy in Localized HER2+ Breast CancerMay 23rd, 2023
- Educated Affected Person® Metastatic Breast Most Cancers Summit HER2 and Triple-Unfavorable Illness Panel: November 12, 2022November 26th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: